Good
Mostly Aligned
Patient Risk:
Low
Summary
The provided AI response only claims that VIAGRA is indicated for erectile dysfunction, which is directly supported by the supplied FDA label. However, it does not evaluate other label-relevant areas (e.g., dosing, contraindications, warnings/precautions, drug interactions, and populations), limiting overall alignment.
Category Scores
Accurate Statements
VIAGRA is indicated for the treatment of erectile dysfunction.
Label section 1 INDICATIONS AND USAGE: "VIAGRA is indicated for the treatment of erectile dysfunction."
Unsupported Statements
Contradictions
Important Omissions
No evaluation of dosing and administration details, contraindications (including nitrates/NO donors), warnings and precautions, drug interactions, or adverse reactions. The AI response also does not address any safety-critical counseling, pediatric use, or geriatrics considerations present in the supplied label text.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Because the AI response only restates the approved indication and does not provide dosing, contraindication, warning, interaction, or population-specific guidance, it does not introduce label-inconsistent safety instructions.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Incomplete audit coverage: only the indication was assessed; other label elements were not evaluated.
Suggested Improvement
Extend the audit to include label-supported dosing/administration, contraindications (e.g., nitrates/NO donors), warnings/precautions, drug interactions, adverse reactions, and relevant special populations using the provided label sections.